The criteria for optimal down-regulation with gonadotropin-releasing hormone-agonist: a retrospective cohort study

References

• Calhaz-Jorge C, Leal F, Cordeiro I, et al. Pituitary down-regulation in IVF cycles: is it necessary to use strict criteria? J Assist Reprod Genet 1995;12:615–19
   PubMed Web of Science ®Google Scholar
• Barash A, Weissman A, Manor M, et al. Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program. Fertil Steril 1998;69:496–9
   PubMed Web of Science ®Google Scholar
• Antoine JM, Salat-Baroux J, Alvarez S, et al. Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in-vitro fertilization: a prospective randomized comparison. Hum Reprod 1990;5:565–9
   PubMed Web of Science ®Google Scholar
• Tummon IS, Daniel SA, Kaplan BR, et al. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization. Fertil Steril 1992;58:563–8
   PubMed Web of Science ®Google Scholar
• Horvath PM, Styler M, Hammond JM, et al. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 1988;49:159–62
   PubMed Web of Science ®Google Scholar
• Rizk B, Tan SL, Kingsland C, et al. Ovarian cyst aspiration and the outcome of in vitro fertilization. Fertil Steril 1990;54:661–4
   PubMed Web of Science ®Google Scholar
• Senoz S, Gulekli B, Turhan NO, et al. Do the suppression criteria in GnRH-a cycles predict in vitro fertilization outcome? Gynecol Endocrinol 1995;9:91–6
   PubMed Web of Science ®Google Scholar
• Ron-El R, Herman A, Golan A, et al. The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist. Fertil Steril 1990;54:233–7
   PubMed Web of Science ®Google Scholar
• Lahoud R, Al-Jefout M, Tyler J, et al. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. Hum Reprod 2006;21:2645–9
   PubMed Web of Science ®Google Scholar
• Xu B, Li Z, Zhang H, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10 000 cycles. Fertil Steril 2012;97:1321–7
   PubMed Web of Science ®Google Scholar
• Zheng Y, Dong X, Huang B, et al. The artificial cycle method improves the pregnancy outcome in frozen-thawed embryo transfer: a retrospective cohort study. Gynecol Endocrinol 2015;31:70–4
   PubMed Web of Science ®Google Scholar
• Zheng Y, Li Z, Xiong M, et al. Hormonal replacement treatment improves clinical pregnancy in frozen-thawed embryos transfer cycles: a retrospective cohort study. Am J Transl Res 2013;6:85–90
   PubMed Web of Science ®Google Scholar
• Meldrum DR. Pregnancies and deliveries per fresh cycle are no longer adequate indicators of in vitro fertilization program quality: how should registries adapt? Fertil Steril 2013;100:620–1
   PubMed Web of Science ®Google Scholar
• Barnhart KT. Live birth is the correct outcome for clinical trials evaluating therapy for the infertile couple. Fertil Steril 2014;101:1205–8
   PubMed Web of Science ®Google Scholar
• Zegers-Hochschild F, Adamson GD, de Mouzon J, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril 2009;92:1520–4
   PubMed Web of Science ®Google Scholar
• Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online 2004;8:635–43
   PubMed Web of Science ®Google Scholar
• Rutherford AJ, Subak-Sharpe RJ, Dawson KJ, et al. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J (Clin Res Ed) 1988;296:1765–8
   PubMed Web of Science ®Google Scholar
• Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update 2012;18:73–91
   PubMed Web of Science ®Google Scholar
• Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188–91
   PubMed Web of Science ®Google Scholar
• Baerwald AR, Adams GP, Pierson RA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril 2003;80:116–22
   PubMed Web of Science ®Google Scholar
• Ibrahim ZH, Matson PL, Buck P, et al. Use of buserelin in an IVF programme for pituitary-ovarian suppression prior to ovarian stimulation with exogenous gonadotrophins. Hum Reprod 1990;5:258–62
   PubMed Web of Science ®Google Scholar
• Nakamura S, Douchi T, Oki T, et al. Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding. Obstet Gynecol 1996;87:722–5
   PubMed Web of Science ®Google Scholar
• Schmitz C, Bocca S, Beydoun H, et al. Does the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age? J Assist Reprod Genet 2012;29:877–82
   PubMed Web of Science ®Google Scholar
• Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001;179:39–46
   PubMed Web of Science ®Google Scholar
• Filicori M, Cognigni GE, Samara A, et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update 2002;8:543–57
   PubMed Web of Science ®Google Scholar
• Shoham Z, Mannaerts B, Insler V, Coelingh-Bennink H. Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil Steril 1993;59:738–42
   PubMed Web of Science ®Google Scholar
• Merviel P, Antoine JM, Mathieu E, et al. Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer. Fertil Steril 2004;82:119–25
   PubMed Web of Science ®Google Scholar
• Bosch E, Escudero E, Crespo J, et al. Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome. Fertil Steril 2005;84:1529–32
   PubMed Web of Science ®Google Scholar
• Baerwald AR, Adams GP, Pierson RA. Characterization of ovarian follicular wave dynamics in women. Biol Reprod 2003;69:1023–31
   PubMed Web of Science ®Google Scholar
• Dogan MM, Uygur D, Alkan RN, et al. Prediction of pituitary down-regulation by evaluation of endometrial thickness in an IVF programme. Reprod Biomed Online 2004;8:595–9
   PubMed Web of Science ®Google Scholar
• Yaman C, Ebner T, Sommergruber M, et al. Three-dimensional endometrial volume estimation as a predictor of pituitary down-regulation in an IVF-embryo transfer programme. Hum Reprod 2000;15:1698–702
   PubMed Web of Science ®Google Scholar
• Child TJ, Sylvestre C, Tan SL. Endometrial volume and thickness measurements predict pituitary suppression and non-suppression during IVF. Hum Reprod 2002;17:3110–13
   PubMed Web of Science ®Google Scholar
• Geber S, Vaintraub MT, Rotschild G, Sampaio M. Doppler of the uterine arteries combined with endometrial thickness correlate well with the degree of pituitary suppression in women treated with long-acting GnRH agonists. Arch Gynecol Obstet 2013;287:369–73
   PubMed Web of Science ®Google Scholar
• Kasius A, Smit JG, Torrance HL, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update 2014;20:530–41
   PubMed Web of Science ®Google Scholar
• Revelli A, Chiado A, Dalmasso P, et al. “Mild” versus “long” protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial. J Assist Reprod Genet 2014;31:809–15
   PubMed Web of Science ®Google Scholar
• Niu Z, Chen Q, Sun Y, Feng Y. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis. Gynecol Endocrinol 2013;29:1026–30
   PubMed Web of Science ®Google Scholar